Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors

  • Matthias Kolberg, Jarle Bruun, Astrid Murumägi, John P. Mpindi, Christian H. Bergsland, Maren Høland, Ina A. Eilertsen, Stine A. Danielsen, Olli Kallioniemi, Ragnhild A. Lothe
  • Molecular Oncology, July 2017, Wiley
  • DOI: 10.1002/1878-0261.12086

The authors haven't yet claimed this publication.

Read Publication


In partnership with:

Link to Wiley showcase